cs.LGJul 5, 2026

LeukocyteCount: Automatic Identification and Counting for leukocytes using Deep Learning

Authors: Ahmed M. Sayed, Sondos A. Refaat, Abdallah M. Mostafa, Mariam S. El-Rahmany, Ensaf Hussein Mohamed

Organizations: Faculty of Computers and Artificial Intelligence, Helwan University, Cairo, Egypt · 2Computer Science Department, Faculty of Computers and Artificial Intelligence, Helwan University, Cairo, Egypt. · School of Information Technology and Computer Science · School of Information Technology and Computer Science (ITCS), Nile University, Giza, Egypt.

Abstract

Diagnosing and monitoring diseases frequently involves the analysis of human biological samples, with blood analysis being pivotal. Specifically, leukocytes, or white blood cells (WBCs), are essential markers for evaluating the body's defense mechanisms against infections. Traditional methods for WBC counting and classification are labor-intensive and prone to inaccuracies, primarily due to human error. The conventional processes for blood cell analysis, especially those concerning WBCs, are beset with difficulties. These include the laborious nature of manual counting and the susceptibility to errors, which can significantly impact the accuracy and reliability of disease diagnosis and monitoring. This study proposes an automated, machine learning-based solution aimed at mitigating the identified challenges. By employing a hybrid model that integrates Yolov5 for the detection of WBCs, coupled with a finely tuned, pre-trained MobileNetV2 model and a Logistic Regression classifier, the study innovates in the accurate identification, counting, and classification of WBCs into four distinct types. The methodology leverages the BCCD dataset for training and validation purposes. The application of the proposed hybrid machine learning model has yielded remarkable results, demonstrating a detection accuracy rate of 98% through the Yolov5 stage, and an unparalleled classification accuracy of 99.04% in subsequent stages utilizing MobileNetV2 and Logistic Regression. Additionally, Our proposed YOLOv5-based RBC detection module achieves an F1 score of 99.73%, which outperforms the baseline. These findings underscore the model's potential in transforming traditional laboratory practices for WBC analysis, offering a path towards more accurate, efficient, and reliable disease diagnostics and monitoring.

Explore similar work

CardsList
Apr 25, 2026cs.CV

A Hierarchical Ensemble Inference Pipeline for Robust White Blood Cell Classification Under Domain Shifts

Automated white blood cell (WBC) classification is essential for scalable leukaemia screening. However, real-world deployment is challenged by domain shifts caused by staining protocols, scanner characteristics, and inter-laboratory variability, which often degrade model performance. The White Blood Cell Classification Challenge (WBCBench) at ISBI 2026 aims to advance robust WBC recognition, with a focus on accurately identifying blast cells and other clinically critical rare subtypes. We propose a memory-augmented, hierarchical ensemble pipeline for WBC classification under domain shifts, leveraging a feature bank and a DinoBloom backbone fine-tuned with LoRA. Our three-stage inference hierarchy combines k-nearest neighbors (kNN) retrieval at each level, reducing over-reliance on any single decision. Evaluated on the WBCBench dataset, our method ranks within the top ten by macro F1-score in the final testing phase.
Ruyi Dai, Tingkwong Ng, Hao Chen
Peripheral Blood SmearMultiple Instance LearningEnsembleImage ClassificationDomain ShiftBenchmark Datasets
AskPDF
Jun 9, 2026cs.CV

Patient-Level Diagnosis of Acute Myeloid Leukemia via Deep Learning Analysis of Bone Marrow Smear

Bone marrow smear review remains important for acute myeloid leukemia (AML) assessment, but manual single-cell interpretation is labor-intensive and patient-level diagnosis requires aggregation of many cellular observations. We present a cell-to-patient deep learning pipeline for AML-assisted diagnosis from bone marrow smear images. The study included 258 patients from six anonymized centers, including a main cohort of 169 patients from Centers 1-3 and an external validation cohort of 89 patients from Centers 4-6. A 16-category cell annotation vocabulary was used to describe the global cellular composition, including granulocytic, monocytic, erythroid, lymphoid, eosinophilic, and other cells. Rather than identifying strict AML blasts or leukemic blasts, the model targets an expert-defined composite category termed Composite Blast-like Cells (CBLC), comprising N, N1, M, M1, R, R1, J, and J1 according to the project-wide morphological standard. A fixed YOLO-based segmentation module detected cells, predicted contours were matched to expert polygon annotations by contour IoU, and standardized single-cell crops were generated. An EfficientNet-B0 classifier was trained through a two-stage GT-to-YOLO and YOLO-to-YOLO strategy with class-imbalance correction, center-border regularization, and morphology-assisted supervision. Cell-level predictions were aggregated into patient-level CBLC ratios for AML-oriented diagnostic support. The pipeline achieved stable internal validation and maintained external generalization, with ensemble weighted F1-scores of 0.9076, 0.8696, and 0.9124 on Centers 4, 5, and 6, respectively.
Yuqi Ma, Tianyi Wang, Weihua Meng +6
Peripheral Blood SmearSingle-Cell Rna
AskPDF
Apr 17, 2026cs.CV

Early Detection of Acute Myeloid Leukemia (AML) Using YOLOv12 Deep Learning Model

Acute Myeloid Leukemia (AML) is one of the most life-threatening type of blood cancers, and its accurate classification is considered and remains a challenging task due to the visual similarity between various cell types. This study addresses the classification of the multiclasses of AML cells Utilizing YOLOv12 deep learning model. We applied two segmentation approaches based on cell and nucleus features, using Hue channel and Otsu thresholding techniques to preprocess the images prior to classification. Our experiments demonstrate that YOLOv12 with Otsu thresholding on cell-based segmentation achieved the highest level of validation and test accuracy, both reaching 99.3%.
Enas E. Ahmed, Salah A. Aly, Mayar Moner
Peripheral Blood SmearEarly DetectionYolo26Medical Image SegmentationMultilevel Image Thresholding
AskPDF